Combination gene therapy developed at Wyss Institute and Harvard Medical School treats four age-related conditions

Innovations in targeting and binding microbes, sequencing nucleic acids, creating sensitive artificial skin, modifying the optical properties of thin films, and more

Harvard stem cell research, currently in mice, receives support from Sarepta to advance in-vivo genome editing toward prospective therapy

Lab1636 commits to advance certain Harvard innovations toward a possible therapeutic for tactile hypersensitivity experienced in autism spectrum disorders